Suchergebnisse - "Yajin Chen"

Andere Suchmöglichkeiten:
yajin chen » yan chen (Erweiterte Suche), yin chen (Erweiterte Suche)

1

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma

von: Xuelian Huang

2022, in: Frontiers in Molecular Biosciences

Wird geladen...
2

A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma

von: Jie Chen

2020, in: Frontiers in Genetics

Wird geladen...
3

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma

von: Sicong Zhu

2019, in: Cancer Medicine

Wird geladen...
4

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

von: Wenliang Tan

2023, in: Journal of Advanced Research

Wird geladen...
5

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]

von: Wenliang Tan

2022, in: EBioMedicine

Wird geladen...
6

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinomaResearch in context

von: Wenliang Tan

2019, in: EBioMedicine

Wird geladen...
7

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway

von: Lei Yang

2022, in: Cell Death and Disease

Wird geladen...
8

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma

von: Hongkai Zhuang

2022, in: Frontiers in Oncology

Wird geladen...
9

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas

von: Hongkai Zhuang

2021, in: Frontiers in Immunology

Wird geladen...
10

CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA

von: Chenwei Tang

2024, in: Cell Death and Disease

Wird geladen...
11

Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study

von: Sheng-Long Ye

2018, in: BMC Cancer

Wird geladen...
12

Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial

von: Zhenggang Ren

2022, in: Liver Cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!